Schroder Ventures
VC Fund
London, United Kingdom
Schroder Ventures is a VC fund in London focused on Biotechnology and Health Care. Schroders is a global asset management company with £103.1 billion (EUR 111.3 billion / $147.7 billion) under management as at 31 March 2009. their clients include corporations, insurance companies, local and public authorities, charities, pension funds, high net worth individuals and retail investors.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries Schroder Ventures invests in
BiotechnologyHealth CareMedicalMedical DevicePharmaceutical
Stages Schroder Ventures invests in
Series CSeries BSeries APost-IPO EquitySeries D
Countries Schroder Ventures invests in
United StatesUnited KingdomGermanySingaporeCanada
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kathleen Jordan Stowe
|
|||
|
Matthew Rho
|
|||
|
Olaf Siedler
|
|||
Investment Focus
Industry
- Biotechnology 12 (46%)
- Health Care 8 (31%)
- Medical 5 (19%)
- Medical Device 5 (19%)
- Pharmaceutical 5 (19%)
Stage
- Series C 7 (27%)
- Series B 5 (19%)
- Series A 3 (12%)
- Post-IPO Equity 3 (12%)
- Series D 2 (8%)
Country
- United States 16 (62%)
- United Kingdom 4 (15%)
- Germany 2 (8%)
- Singapore 2 (8%)
- Canada 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Kathleen Jordan Stowe
Principal
|
Principal | Total investments: 0 | Find email | |
|
Matthew Rho
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Olaf Siedler
Portfolio Manager
|
Portfolio Manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Capitan Silver
|
Capitan Silver is a mining company that specialises in acquiring, exploring, and developing mineral properties. The company explores silver, gold, and base metal resources, conducting drilling, geological surveys, and feasibility studies. The company is engaged in exploring its 100%-owned, high-grade silver Cruz de Plata Project. | $4.4M / Post-IPO Equity / Dec 23, 2025 | |
Digital Barriers
|
Digital Barriers is a world leader in edge-intelligent solutions for the global surveillance and security markets. The company is headquartered between the United Kingdom and United States, with regional operations covering Europe, the Middle East and Asia-Pacific.We provide software solutions and cloud services to manage the capture, analysisand streaming of live video, enabling actionable video intelligence to be delivered where it’s needed, when it’s needed. Our software-based solutions, supplied with highly-performant hardware where required, readily integrate with video management systems, cameras and sensors, and have been sold to flagship defence, security and law enforcement agencies in more than fifty countries around the world. We also resell through large commercial channel partners and on a licensed basis to leading technology companies and service providers.Digital Barriers established its reputation by providing integrated mission-critical surveillance and security solutions to some of the best known surveillance and security agencies in the world. We reinvented the art of the possible through the deployment of new, proprietary technology – our favorite customer references all contain the phrase “game changing”. Digital Barriers solutions are in use around the world every day keeping people safe, at the heart of national security operations and the fight against terrorism and serious and organised crime. We can deliver our software-based solutions as SDKs and licenses, on standard COTS hardware, or on bespoke hardware designed to meet the needs of the most demanding customers across defense, security and law enforcement. | $1.8M / Post-IPO Equity / Nov 12, 2024 | |
Psychiatry Australia
|
At Psychiatry Australia, we handle every aspect of the recruitment journey — from executive search and headhunting within Australia to global relocation and onboarding support for international psychiatrists. We work with hospitals, health services, and clinics nationwide to place the right psychiatrists in the right roles — from metro hubs tounderserved regional areas. | $4M / Pre-Seed / Jan 19, 2024 | |
HIPAA Digital
|
HIPAA Digital - Addiction Treatment Services At HIPAA Digital, we specialize in providing innovative, secure, and compliant solutions for addiction treatment services. Our mission is to empower treatment centers with cutting-edge technology and customized tools that enhance patient care, streamline operations, and ensure HIPAA compliance.Whetheryou're a small clinic or a large rehabilitation center, HIPAA Digital offers services tailored to meet your needs, from secure telehealth platforms to digital patient records and analytics. By combining compassion-driven care with advanced technology, we aim to transform the landscape of addiction treatment while safeguarding patient confidentiality at every step. | $5M / Series A / Jan 31, 2022 | |
Antler
|
Antler is an early-stage venture capital firm that seeks to invest in technology companies. The firm incubates startups from a variety of sectors and offers a global community network of co-founders and access to talent, expert advisors, expansion support, and capital around the world. | $25M / Venture - Series Unknown / Feb 06, 2020 | |
Albert Technologies
|
Albert is the first-ever artificial intelligence marketing platform for the enterprise, driving fully autonomous digital marketing campaigns for some of the world’s leading brands. Created by Albert Technologies Ltd. in 2010, Albert’s mission is to liberate businesses from the complexities of digital marketing – not just by replicating theirexisting efforts, but by executing them at a pace and scale not previously possible. He serves as a highly intelligent and sophisticated member of brands’ marketing teams, wading through mass amounts of data, converting this data into insights, and autonomously acting on these insights, across channels, devices and formats, in real time. This eliminates the manual and time-consuming tasks that currently limit the effectiveness and results of modern digital advertising and marketing. Brands such as Harley Davidson, EVISU, Cosabella, and Made.com credit Albert with significantly increased sales, an accelerated path to revenue, the ability to make more informed investment decisions, and reduced operational costs. | $18M / Post-IPO Equity / Jul 04, 2018 | |
Insulet
|
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. | $50M / Series E / Feb 16, 2006 | |
Lorantis
|
Lorantis develops products for the selective treatment of immunological and inflammatory diseases. It develops therapeutics for immunological diseases, including allergy, asthma, autoimmune diseases, and transplant regulation. The company is based in Cambridge, United Kingdom. | $32.7M / Series C / Oct 19, 2005 | |
Quick Study Radiology
|
Quick Study Radiology provides digital imaging solutions for community hospitals, radiology and oncology practices, and imaging centers. The company offers image and data archiving, and disaster recovery services; monitoring and security services; and networking and web distribution services. It also provides picture archiving and communicationsystems for community hospitals and other facilities, and radiology information systems to store, manage, and distribute patient’s data and imagery. Quick Study Radiology was founded in 1999 and is based in Saint Louis, Missouri. | $1.2M / Series C / Jul 15, 2005 | |
Medifacts International
|
As of February 5, 2010, Medifacts International, Inc. was acquired by CoreLab Partners. Medifacts International, Inc. provides cardiovascular safety monitoring services to the pharmaceutical and biotech industry. The company offers electrocardiogram (ECG) services, digital Holter services, ambulatory blood pressure monitoring, automated bloodpressure, telemedicine, and assessment of arterial stiffness in clinical trials, as well as glucose monitoring and pulmonary services. It also provides consulting and medical writing services, including expert program and protocol design, protocol development, expert interim reports, statistical analysis plans and reports, ECG analysis, regulatory guidance and support, expert summary reports for inclusion in the clinical study reports, and statistical analysis planning and biostatistics, as well as digital data collection, transmission, and analysis. The company was founded in 1985 and is headquartered in Rockville, Maryland with additional offices in Langenfeld, Germany; and Shanghai, China. | Series A / Jan 27, 2005 | |
| See all 26 investments → | |||
Co-Investors
Abingworth
4 deals together
OrbiMed
3 deals together
Perseus-Soros Biopharmaceutical Fund
3 deals together
A.G. Edwards Capital Partners
2 deals together
Alta Partners
2 deals together
BB Biotech Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
Medical Device Investors
11,047 investors
Health Care VC Funds
32,370 investors
Biotech VC Funds
18,864 investors
Biotechnology VC Funds
17,016 investors
Medical VC Funds
16,214 investors
FAQ
What does Schroder Ventures invest in?
Schroder Ventures invests primarily in Biotechnology, Health Care and Medical startups, most often at Series C and Series B stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Schroder Ventures?
Public channels for Schroder Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Schroder Ventures?
The team at Schroder Ventures includes Kathleen Jordan Stowe (Principal), Matthew Rho (Vice President) and Olaf Siedler (Portfolio Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
